SCFD2

Model summary

A soluble adaptor of the early secretory pathway that organizes vesicle docking and fusion between the endoplasmic reticulum and the Golgi apparatus. By using a Sec1/Munc18-type scaffold to bind and stabilize membrane-fusion machinery, it promotes efficient cargo exit from the endoplasmic reticulum and subsequent maturation as cargo progresses toward the Golgi. The protein operates primarily in the cytosol with transient soluble pools that can access nucleoplasmic fractions, and it likely functions by assembling and timing SNARE-dependent fusion events that drive ER-to-Golgi transport.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The sequence is dominated by Sec1/Munc18 (SM) family signatures: IPR001619 (Sec1-like protein family) spans residues 18–669, establishing the overall fold and function class; IPR036045 (Sec1-like superfamily) covers residues 219–674, reinforcing the SM scaffold; and IPR027482 (Sec1-like, domain 2) occupies residues 533–676, marking the C-terminal SM subdomain that typically forms a cradle for SNARE N-terminal peptides. This ordered layout—an extended SM core with a defined domain-2 module—creates a rigid, cup-like binding surface that captures and organizes membrane-fusion machinery. Such SM architectures are non-enzymatic adaptors that stabilize and chaperone SNARE assemblies; this causes a primary molecular function of multivalent protein binding, consistent with GO:0005515 protein binding.

2. 02

   From this SM-driven binding activity, the biological role follows.

   SM adaptors govern vesicle tethering and fusion steps that move cargo from the endoplasmic reticulum to the Golgi apparatus. By stabilizing cognate SNARE complexes and coordinating coat-to-SNARE transitions, this architecture drives endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888). The same assembly logic ensures efficient protein exit from the endoplasmic reticulum (GO:0032527) and supports downstream steps that culminate in protein maturation (GO:0051604) as cargo traverses the early secretory pathway.

3. 03

   Cellular placement is inferred from the soluble SM scaffold and its role at membrane-proximal sites.

   The absence of transmembrane segments and the SM fold’s soluble nature point to a cytosolic pool that transiently associates with membranes, aligning with GO:0005829 cytosol. Early secretory pathway adaptors can also transit through soluble nuclear-adjacent fractions; a nucleoplasmic presence (GO:0005654 nucleoplasm) is compatible with soluble trafficking hubs and transient nucleo-cytoplasmic exchange, even though the core functional locus remains cytosolic.

4. 04

   Mechanistically, the SM fold binds SNARE N-peptides and associated factors to choreograph ER-derived vesicle fusion at the Golgi.

   I hypothesize that this protein recruits and stabilizes ER–Golgi SNAREs and their cofactors, forming a platform that times vesicle docking and fusion. Likely partners include ER–Golgi SNAREs and tethering factors that together assemble a fusion-competent complex; transient interactions with cytosolic coats and small GTPases would couple cargo exit to productive fusion. This cooperative assembly explains how the SM architecture enforces directional flow from ER to Golgi and ensures efficient cargo maturation in the early secretory pathway.